This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

HQK-1004

HemaQuest Pharmaceuticals, Inc.

Drug Names(s): HQK-1004

Description: HQK-1004, a short chain fatty acid (SCFA) compound, acts by inducing the expression of a gene for a viral enzyme, thymidine kinase (TK) and is designed to treat hematologic malignancies associated with viruses.


HQK-1004 News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug